Interferon-α enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells

Journal of Medical Investigation

Volumn 49, Issue 3-4, 2002, Pages 172-181

  Lu, Guangming ^a   Shimizu, Ichiro ^a   Cui, Xuezhi ^a   Itonaga, Mina ^a   Tamaki, Katsuyoshi ^a   Fukuno, Hiroshi ^a   Inoue, Hiroshi ^a   Honda, Hirohito ^a   Ito, Susumu ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Antioxidant enzyme; Hepatic fibrosis; Hepatic stellate cell; Interferon ; Lipid peroxidation; Oxidative stress

Indexed keywords

ALPHA INTERFERON; ANTIOXIDANT; COLLAGEN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; LIVER MITOCHONDRION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; RESPIRATORY BURST; STELLATE CELL; STRESS;

ACTINS; ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INDUCTION; FEMALE; FERRIC COMPOUNDS; GLUTATHIONE PEROXIDASE; HEPATOCYTES; HUMANS; INTERFERON-ALPHA; LIPID PEROXIDATION; LIVER; LIVER CIRRHOSIS; MALE; MITOCHONDRIA, LIVER; NITRILOTRIACETIC ACID; OXIDANTS; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

ANIMALIA;

EID: 0036704534     PISSN: 13431420     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Baron S, Tyring SK, Fleischmann WR Jr, Coppenhaver DH, Niesel DW, Klimpel GR, Stanton GJ, Hughes TK: The interferons: Mechanisms of action and clinical applications. JAMA 266: 1375-1383, 1991
2. Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombari R, Mezzelani P, Corrocher R, De Sandre G: α-Interferon in the treatment of chronic viral hepatitis: Effects on fibrogenesis serum markers. J Hepatol 18: 112-118, 1993
3. 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation. Hepatology 18: 1344-1349, 1993
4. Hiramatsu N, Hayashi N, Kasahara A, Hagiwara H, Takehara T, Haruna Y, Naito M, Fusamoto H, Kamada T: Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. J Hepatol 22: 135-142, 1995
5. Yamada G, Takatani M, Kishi F, Takahashi M, Doi T, Tsuji T, Shin S, Tanno M, Urdea MS, Kolberg JA: Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level. Hepatology 22: 1351-1354, 1995
6. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Toyoda H, Sasa T, Shibata M, Morishima T, Nakano I, Fukuda Y, Kosaka Y, Tameda Y, Nakashima M: Long-term administration of natural interferon-α in patients with chronic hepatitis C: Relationship to serum RNA concentration, HCV-RNA genotypes, histological changes and hepatitis C virus. J Gastroenterol Hepatol 11: 159-165, 1996
7. Rojkind M, Perez-Tamayo R: Liver fibrosis. Int Rev Connect Tissue Res 10: 333-393, 1983
8. Conn HO, Atterbury CE: Cirrhosis. In: Schiff L, Schiff ER, eds. Diseases of the Liver. 7th Edn. JB Lippincott Company, Philadelphia, 1993, pp. 875-934
9. Bissell DM, Roll J: Connective tissue metabolism and hepatic fibrosis. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook ofLiver Disease. 2nd Edn. WB Saunders, Philadelphia, 1990, pp. 424-444
10. Friedman SL: Cellular sources of collagen and regulation of collagen production in liver. Semin Liver Dis 10: 20-29, 1990
11. Gressner AM, Bachem MG: Cellular sources of noncollagenous matrix proteins: Role of fat-storing cells in fibrogenesis. Semin Liver Dis 10: 30-46, 1990
12. Pinzani M: Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther 66: 387-412, 1995
13. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini P, Dianzani MU: Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 194: 1044-1050, 1993
14. Britton RS, Bacon BR: Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 41: 343-348, 1994
15. Tsukamoto H, Rippe R, Niemela O, Lin M: Roles of oxidative stress in activation of Kupffer and Ito cells in liver fibrogenesis. J Gastroenterol Hepatol 10 (Suppl 1): S50-S53, 1995
16. Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGF α and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96: 2461-2468, 1995
17. Lefkowitch JH, Schiff ER, Davis RL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, Balart LA, Ortego TJ, Payne J, Dienstag JL, Gibas A, Jacobson IM, Tamburro CH, Carey W, O'Brien C, Sampliner R, Van Thiel DH, Feit D, Albrecht J, Meschievitz C, Sanghvi B, Vaughan RD, and the Hepatitis Interventional Therapy Group: Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepaittis B. Gastroenterology 104: 595-603, 1993
18. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, K Ishibashi, Matsuura Y, Kimura S, Miyamura T, Koike K: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 4: 1065-1067, 1998
19. Sies H: Strategies of antioxidant defense. Eur J Biochem 215: 213-219, 1993
20. Tribble DL, Aw TY, Jones DP: The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 7: 377-386, 1987
21. Fridovich I: Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem 264: 7761-7764, 1989
22. Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M, Shiba M, Horie T, Amagaya S, Kawada N, Hori H, Ito S: Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats [see comments]. Hepatology 29: 149-160, 1999
23. Bacon BR, Tavill AS, Brittenham GM, Park CH, Recknagel RO: Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 71: 429-439, 1983
24. Morel I, Lescoat G, Cillard J, Pasdeloup N, Brissot P, Cillard P: Kinetic evaluation of free malondialdehyde and enzyme leakage as indices of iron damage in rat hepatocyte cultures. Involvement of free radicals. Biochem Pharmacol 39: 1647-1655, 1990
25. Shimizu I, Mizobuchi Y, Yasuda M, Shiba M, Ma YR, Horie T, Liu F, Ito S: Inhibitory effect of estradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut 44: 127-136, 1999
26. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M: Flow cytometic studies of oxidative product formation by neutrophils: A graded response of membrane stimulation. J Immunol 130: 1910-1917, 1983
27. Kawaguchi T, Noji S, Uda T, Nakashima Y, Takeyasu A, Kawai Y, Takagi H, Tohyama M, Taniguchi N: A monoclonal antibody against COOH-terminal peptide of human liver manganese superoxide dismutase. J Biol Chem 264: 5762-5767, 1989
28. Taniguchi N: Clinical significances of superoxide dismutases: Changes in aging, diabetes, ischemia and cancer. Adv Clin Chem 29: 1-59, 1992
29. Lawrence RA, Burk RF: Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 71: 952-958, 1976
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951
31. Myers DK, Slater EC: The enzymic hydrolysis of adenosine triphosphate by liver mitochondria I. Activities at different pH values. Biochem J 67: 558-572, 1957
32. Pan N, Hori H:The interaction of acteioside with mitochondrial lipid peroxidation as an ischemia/reperfusion injury model. Adv Exp Med Biol 361: 319-325, 1994
33. 2 activity in liposomes composed of unsaturated phospholipids: A structural basis for enzyme activation. Biochim Biophys Acta 961: 316-327, 1988
34. Bautista AP, Meszaros K, Bojta J, Spitzer JJ: Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 48: 123-128, 1990
35. Pietrangelo A: Metals, oxidative stress and hepatic fibrogenesis. Semin Liver Dis 16: 13-30, 1996
36. Baroni GS, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, Ridolfi F, Saccomanno S, Jezequel AM, Benedetti A: Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 27: 720-726, 1998
37. MallatA, Preaux AM, Blazejewski S, Rosenbaum J, Dhumeaux D, Mavier P: Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture. Hepatology 21: 1003-1010, 1995
38. Whalen R, Rockey DC, Friedman SL, Boyer TD: Activation of rat hepatic stellate cells leads to loss of glutathione S-transferases and their enzymatic activity against products of oxidative stress. Hepatology 30: 927-933, 1999
39. Lalazar A, Wong L, Yamasaki G, Friedman SL: Early genes induced in hepatic stellate cells during wound healing. Gene 195: 235-243, 1997
40. Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA: Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 27: 1317-1323, 1998
41. Spolarics Z: Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am J Physiol 270: G660-G666, 1996
42. Radwanski E, Perentesis G, Jacobs S, Oden E, Affrime M, Symchowicz S, Zampaglione N: Pharmacokinetics of interferon α-2b in healthy volunteers. J Clin Pharmacol 27: 432-435, 1987
43. Witter F, Barouki F, Griffin D, Nadler P, Woods A, Wood D, Lietman P: Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose of administration in healthy volunteers. Clin Pharmacol Ther 42: 567-575, 1987
44. Smith CI, Weissberg J, Bernhardt L, Gregory PB, Robinson WS, Merigan TC: Acute Dane particle suppression with recombinant leucocyte A interferon in chronic hepatitis B virus infection. J Infect Dis 148: 907-913, 1983
45. Nishigushi S, Kuroki T, Nakatani S, Morimoto H, Takeda T, Nakajima S, Shiomi S, Seki S, Kobayashi K, Otani S: Randomised trial of effects of interferon-α on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346: 1051-1055, 1995
46. Poynard T, Opolon P: Hepatitis C: Somber views of natural history and optimistic views of interferon treatment? Hepatology 27: 1443-1444, 1998